Journals Library


EME - 15/48/20

A multicentre prospective randomised open-label blinded end-point controlled trial of cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent cardiac toxicity in anthracycline treated breast cancer patients

Project title: A multicentre prospective randomised open-label blinded end-point controlled trial of cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent cardiac toxicity in anthracycline treated breast cancer patients

Call to action: 15/48 15/48 EME Researcher Led

Research type: Primary Research

Chief investigator: Dr Peter HenriksenORCID logoorcid.org/0000-0003-4974-0344

Contractor: The University of Edinburgh

Cost: £937,298.36

Co-investigators: Dr Iain Macpherson, Dr John Payne, Dr Ninian Lang, Dr Olga Oikonomidou, Dr Peter Hall, Ms Abigail Marks, Ms Heather McVicars, Professor Chris Twelves, Professor David Newby, Professor Nicholas Mills, Professor Steff Lewis.

Started: April 2017 | Status: Research in progress

ISRCTN: 24439460

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.